DOMINANT ANGLE
Seoul retains from this Nobel the therapeutic promise of optogenetics, from vision restored to the blind to hope against autism and depression, and recounts it above all through its laureates.
Dominant angle identified — does not reflect unanimity of this country’s media
KEY POINTS
- 01
The 2026 physiology or medicine prize goes to Karl Deisseroth (54 years old), Peter Hegemann (71 years old), and Georg Nagel (73 years old), with an award of 12 million Swedish crowns (1.2 million dollars).
- 02
Clinical trials are seeking to restore the vision of people blinded by retinitis pigmentosa by inserting a light-sensitive protein into the retina (Korea Times).
- 03
Karl Deisseroth ended his interviews at 6:30 for a one-hour break to prepare meals for his children (Korea Times).
ANALYSIS
Seoul, October 6, 2026. The Korea Times and the Korea Herald, which pick up agency dispatches, announce that the 2026 Nobel Prize in Physiology or Medicine was awarded on Monday, October 5, to American Karl Deisseroth, 54, and Germans Peter Hegemann, 71, and Georg Nagel, 73, for their "discoveries concerning light-activated ion channels and optogenetics". The prize, announced at the Karolinska Institute in Stockholm, opens the Nobel week and amounts to 12 million Swedish crowns, or $1.2 million.
The Korea Herald details the scientific chain: Peter Hegemann explores how a single-celled green alga swims towards light; with Georg Nagel, he discovers a protein that, when exposed to blue light, opens a channel and creates an electrical impulse. Karl Deisseroth then uses the gene of this protein to manufacture a light switch for the neurons of living mice. Thomas Perlmann, Secretary General of the Nobel Assembly, states that the method "is used in laboratories around the world to reveal the mysteries of the brain".
The Korea Times emphasizes the clinical applications. Trials restore vision to people blinded by retinitis pigmentosa thanks to a light-sensitive protein inserted into the retina, and researchers hope for more precise cochlear implants than current electronic devices. According to the newspaper, Karl Deisseroth, who also practices as a psychiatrist, mentions hope for patients with autism and depression.
A second article in The Korea Times takes a portrait tone. The laureate, described as a night owl, received the call from the committee after re-reading articles and writing to his students, then interrupted his interviews at 6:30 for a one-hour break to prepare meals for his children. His wife, Michelle Monje-Deisseroth, is also a researcher at the Howard Hughes Medical Institute and a pediatric neuro-oncologist at Stanford.
The two titles do not mention any connection to South Korea in the provided passages: the coverage is that of a global scientific fact, treated by dispatch, without local editorial commentary on research funding or competition between nations. The dominant lens remains medical: what light applied to neurons can change for brain and vision diseases.
